Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
CGTN: Migrating herd of wild Asian elephants in Yunnan takes a break 2021-06-08 22:40
Ruder Finn and Consumer Search Group Jointly Announce the 2021 CHINA LUXURY FORECAST 2021-06-08 22:26
Glory Star Enters into Strategic Cooperation with Haier Group to Develop New "Home Life Service" Channel 2021-06-08 19:30
Innoforce Pharmaceuticals to Participate in BIO International Digital Convention 2021-06-08 19:00
"Memoria" Co-produced by iQIYI and Xstream Pictures Joins Cannes International Film Festival 2021 Competition Lineup 2021-06-08 17:18
Zoomlion Launches Operations of New Factory in Europe Further Driving Localized Manufacturing 2021-06-08 17:02
GWM's Globalization Strategy is accelerated on 2nd Anniversary of Tula Factory in Russia 2021-06-08 16:23
Less Worries, More Confidence: OPPO Support Is Here for You 2021-06-08 15:42
Inspiring Women's Healthcare: Mindray Unveils Nuewa I9, a New OB/GYN Diagnostic Ultrasound System 2021-06-08 15:37
Ying Hai Announces Possible Acquisition of a Zhuhai Travel Company 2021-06-08 11:35
2021 SNEC丨Arctech Signed MoU 1GW Solar Tracker Delivery Worldwide 2021-06-08 11:01
CGTN launches 'Media Challengers' theme song 2021-06-08 09:58
CGTN: Peng Liyuan calls for global efforts in AIDS and TB prevention and treatment 2021-06-08 09:37
PingPong Payments launches new PLN and SEK currency exchange services 2021-06-08 09:00
Innovent Biologics and IASO Biotherapeutics to Present Updated Data from its Anti-BCMA CAR-T Therapy in Relapsed/Refractory Multiple Myeloma at European Hematology Association (EHA) Congress 2021-06-08 08:00
Mech-Mind Announces New-Gen Mech-Eye Pro Enhanced Industrial 3D Camera to Enable Smarter Robotics of Industry 4.0 2021-06-08 08:00
Live from ASCO 2021 | Ascentage Pharma Delivers Oral Presentation Featuring Updated Data Demonstrating Promising Efficacy and Safety of Bcl-2 Inhibitor Lisaftoclax (APG-2575) in Patients with Relapsed or Refractory CLL/SLL 2021-06-08 07:30
Live from ASCO 2021 | Ascentage Pharma Presents Updated Results of MDM2-p53 Inhibitor Alrizomadlin (APG-115) Demonstrating an ORR of 24.1% Including Complete Response in Combination with Pembrolizumab in Patients with Advanced Melanoma Resistant or Refractory to Prior Immuno-Oncologic Drugs 2021-06-08 07:21
India's largest bank SBI invests in leading digital payments firm Cashfree 2021-06-07 23:29
Second Global Health Forum of Boao Forum for Asia: A Call for Innovation and Collaboration to Promote the Progress of the Global Health System 2021-06-07 21:35
1 525 526 527 528 529 1160